Cantor Fitzgerald analyst Carter Gould initiated coverage of Merck (MRK) with a Neutral rating and $85 price target Shares have been “a ...

Pfizer and AbbVie shares declined more than 4%, Merck dropped almost 4%, and Eli Lilly pulled back over 3% in early trading. Daily Merck & Company, Inc. Dow pharmaceutical components are leading ...

The image of the flipped logo has been edited to add "eyes" so that it more closely resembles a KKK hood. On April 1, 2025, TikTok user @thedisciplinedfatkid posted a video (archived) in which he ...

More than 200 members of the United Steelworkers Union Local 10-00086 at Merck & Co. rallied outside Building 53 near Gate 1 at the Upper Gwynedd pharmaceutical giant Wednesday afternoon in support of ...

Beyond logos, create business cards, social media kits, favicons, and more. Download high-resolution PNG, JPEG, and vector files, and get brand guidelines for fonts and colors. Make unlimited changes ...

The last weekend of March brings a celestial event that skywatchers won't want to miss. There will be a partial solar eclipse on March 29 that will be visible in part of the U.S. as well as parts ...

Discover the top 10 gaming logos of all time! Explore iconic designs that shaped the gaming industry and learn what makes them unforgettable. Most people think gaming is just entertainment. They're ...

The university claims using the logo in the scene "simply goes too far." By Lexi Carson [The following story contains spoilers from the latest episode of The White Lotus, “Denials.”] ...

Merck (MRK) released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA is reviewing the application for approval. The data showed that ...

Merck & Co.’s subcutaneous (SC) formulation of Keytruda has matched up to the original intravenous (IV) version on two blood concentration measurements, paving way for a potential FDA approval ...

A Merck logo is shown on a scientist's lab coat. The Food and Drug Administration, on Sept. 4, 2014, granted accelerated approval to Merck's Keytruda for treating melanoma that has spread or can't be ...